Stephen Lieber, longtime CEO and president of the Healthcare Information and Management Systems Society (HIMSS), has announced he’ll be retiring at the end of 2017. The search for his replacement has already begun.

Biopharmaceutical company Allergan is acquiring Acelity’s LifeCell, a regenerative medicine unit, for $2.9 billion, according to a news release.

Wide variation in prices for the same procedures at hospitals around New York State isn’t based on quality of care, but rather the facility’s market power.

CMS hopes to strengthen the risk pool on Affordable Care Act’s insurance marketplace for the 2018 plan year, even as insurers remain uncertain about the exchanges with the incoming Congress and President-elect promising to repeal the law.

Technology can improve organization of patient files, create limbs with 3D printers and connect patients and doctors around the world. Jon Markman, president of Markman Capital Insight, thinks that technology just might be able to cure healthcare.

Beginning January 19, 2017, powdered medical gloves will be banned by the Food and Drug Administration (FDA), which cites “an unreasonable and substantial risk of illness or injury.”

A Chicago Tribune investigation tested how often pharmacists would recognize and warn patients about potentially dangerous interactions between two of their prescriptions.

Testing for multiple drug-resistant pathogens in rural parts of developing countries is often difficult due to the lack of laboratories and resources. Researchers have developed a portable detection system designed to improve care to these remote patients by identifying 16 different pathogens.